logo
Lab-grown meat goes on sale in UK dog food

Lab-grown meat goes on sale in UK dog food

Yahoo09-02-2025

Dog food made from meat that was grown in factory vats has gone on sale in the UK.
Supplier Meatly said the "chick bites" were the first pet food products made from cultivated meat to be sold commercially anywhere in the world.
It said the technology could eventually "eliminate farm animals from the pet food industry" and reduce carbon emissions as well as the use of land and water in meat production.
A trial of the dog treats began at a pet store in Brentford, London, on Friday.
Owen Ensor, who founded London-based Meatly in 2022, said the manufacturing process was similar to brewing beer.
He said: "You take cells from a single chicken egg. From that we can create an infinite amount of meat for evermore.
"We put it in large, steel fermenters... and after a week we're able to harvest healthy, delicious chicken for our pets."
Lab-grown meat, which is genetically indistinguishable from traditionally produced meat, has proved a divisive topic in some countries.
In 2020, Singapore became the first country to authorise the sale of cell-cultivated meat for human consumption, followed by the United States three years later.
However, Italy and the US states of Alabama and Florida have instituted bans.
Advocates point to environmental benefits, while critics say cultivated meat is expensive and could harm farming.
Prof Guy Poppy, from the University of Bristol, said it addressed concerns over animal welfare.
The former chief scientific adviser at the government's Food Standards Agency added: "This is an opportunity to offer the advantages of meat but without the carbon and environmental footprint."
Prof Andrew Knight, from the University of Winchester, said: "About 20% of all the meat that is consumed by high pet-owning nations - and that would include the United Kingdom - is actually consumed by pets not people."
At a Bristol pet store and cafe, dog owners interviewed by the BBC had mixed views.
Charlotte Bloyce said her pet's carbon footprint was worth considering, while Allie Betts said she would not eat lab-grown meat herself and was reluctant to feed it to her dog.
The British Veterinary Association told the BBC it wanted more research on the safety and sustainability of cultivated meat.
Mr Ensor said he could understand people being "a little bit squeamish" about the product.
However, he said it was approved by food regulators and did not contain hormones, steroids and other chemicals sometimes found in meat.
Meatly's chief executive said the product had become much more commercially viable.
He acknowledged: "Currently it is expensive but we've made great strides bringing down the cost dramatically over the last two years and are going to continue to do so."
You can follow BBC Hampshire & Isle of Wight on Facebook, X, or Instagram.
Lab-raised meat 'not the enemy', say farmers
Lab-grown meat set to be sold in UK pet food
Ron DeSantis bans 'global elite' lab-grown meat

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

8 ice cream flavors recalled in Ohio
8 ice cream flavors recalled in Ohio

Yahoo

time10 minutes ago

  • Yahoo

8 ice cream flavors recalled in Ohio

WAUSEON, Ohio — An Ohio-based creamery has announced a voluntary recall due to undeclared allergens in eight of their ice cream flavors. According to the Ohio Department of Agriculture, Turkeyfoot Creek Creamery of Wauseon, Ohio, is recalling the following flavors of ice cream; Avalanche, Chocolate Peanut Butter, Chocolate Strawberry, Chocolate Brownie Bites, Cookies and Cream, Cookie Dough, Cacao and Mocha. Massive egg recall hits Ohio Walmart stores The affected products are all packaged in pint containers and were distributed to six stores, located in Canton, Cleveland, West Unity, and Arlington, Ohio. As well, as two stores located out of state, with one in Fort Wayne, Indiana, and the other in Hudson, Michigan, read a press release from the Ohio Department of Agriculture. Young mother killed in shooting at Cleveland Metroparks Mill Creek Falls 'There have been no reports of illness involving products addressed in this recall, however, individuals exhibiting signs or symptoms of an allergic reaction after consuming Turkeyfoot Creek Creamery Ice Cream involved in this recall should contact a physician immediately,' stated the release. All affected products have been removed from store shelves. Consumers can return recalled products to the place of purchase for a refund. Consumers with questions can call 419-583-7124. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Topeka's KMC Dermatology Is First in Kansas to Offer Nonsurgical GentleCure™ Treatment Option for Common Skin Cancer
Topeka's KMC Dermatology Is First in Kansas to Offer Nonsurgical GentleCure™ Treatment Option for Common Skin Cancer

Yahoo

time26 minutes ago

  • Yahoo

Topeka's KMC Dermatology Is First in Kansas to Offer Nonsurgical GentleCure™ Treatment Option for Common Skin Cancer

BURR RIDGE, Ill., June 11, 2025 /PRNewswire/ -- SkinCure Oncology, the industry leader in providing a comprehensive cancer center model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT or IGSRT) for the treatment of nonmelanoma skin cancer (NMSC), presented to dermatology patients and professionals as the GentleCure Experience™, today announced its first availability in Kansas at an event at Topeka's KMC Dermatology. Image-Guided SRT is the only treatment for nonmelanoma skin cancer (basal and squamous cell carcinoma) that uses ultrasound imaging to help clinicians direct low-level x-rays to targeted areas of the skin, killing cancer cells. For patients treated with Image-Guided SRT, the cure rate (freedom from recurrence at six years) has been shown to be greater than 99 percent, with researchers reporting that for appropriately selected early-stage nonmelanoma skin cancers, Image-Guided SRT is a clinically equivalent alternative to Mohs surgery and statistically significant in superiority to non-Image-Guided SRT. Dr. Joseph Gadzia of KMC Derm noted, "More than 26,000 individuals in Kansas are expected to be diagnosed with nonmelanoma skin cancer this year. We know that sun exposure is the main cause of this type of cancer but there are other factors as well. For those who have been diagnosed with nonmelanoma skin cancer, we now offer a nonsurgical treatment option which we call the GentleCure Experience, and we are proud to be the first practice in the state to offer it." Dr. Gadzia also added, "While most common skin cancers have been treated with Mohs surgery, this newer treatment option achieves close to the same success rate with no surgery, no surgical scarring, and no bleeding. As of this past April, more than 100,000 patients have been successfully treated with Image-Guided SRT in the United States." Other speakers included Dr. Shekhar Challa; U.S. Senator Roger Marshall via video; Topeka Mayor Michael Padilla; Aaron Mays, Chairman of the Shawnee County Board of Commissioners; and John Mugler, District Director, Office of Senator Marshall. In addition, Kansas Governor Laura Kelly issued a gubernatorial proclamation declaring June 8 – 14 "Kansas Nonmelanoma Skin Cancer Awareness Week," noting that KMC Dermatology is the first practice in the state of Kansas to offer Image-Guided SRT. Kerwin Brandt, chief executive officer of Chicago-based SkinCure Oncology, said, "We are delighted to partner with KMC Dermatology to offer this highly effective, noninvasive treatment option for their patients. It is critical that patients everywhere have the choice of treating their nonmelanoma skin cancer without surgery." About SkinCure OncologySkinCure Oncology is the industry leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT or IGSRT), the most advanced nonsurgical treatment for common skin cancer. The company partners with quality-focused dermatologists, Mohs surgeons and other physicians to bring cancer center-level radiation therapy treatment to private practices. Presented to patients as the GentleCure Experience™, Image-Guided SRT is available from some 500 physicians nationwide, with more than 100,000 patients having been treated. Learn more about the company at and visit for helpful consumer and patient information. Media Contact:Matt RussellRussell Public Communications520-232-9840mrussell@ View original content to download multimedia: SOURCE SkinCure Oncology Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Texas to expand psychedelic research with $50M ibogaine investment
Texas to expand psychedelic research with $50M ibogaine investment

Yahoo

time2 hours ago

  • Yahoo

Texas to expand psychedelic research with $50M ibogaine investment

AUSTIN (KXAN) — Texas Gov. Greg Abbott is holding a bill signing ceremony Tuesday for legislation that invests $50 million into clinical research of ibogaine — a naturally occurring psychedelic substance that could treat post-traumatic stress disorder, opioid use disorder and other mental health conditions. For years, veterans and others suffering from PTSD have sought ibogaine treatment in Mexico, where the substance is not heavily regulated. In the United States, ibogaine is classified as a Schedule 1 drug, the most restrictive drug category. Other drugs classified under Schedule 1 include psilocybin, LSD and heroin. According to the legislative summary of SB 2308, the implications for those with opioid use disorder are lifechanging; a single administration of ibogaine in a controlled setting has been shown to stop withdrawal symptoms and reduce drug cravings long-term. RELATED: Lawmakers hope to expand medical marijuana program as state bans intoxicating hemp products 'Preliminary reports also suggest benefits in cognitive function, mood regulation, and sleep among individuals with [traumatic brain injury] and PTSD—conditions prevalent among U.S. veterans,' the bill text read. The new legislation will create a program within the Texas Health and Human Services Commission to support Texas-based trials of ibogaine through the FDA. Ibogaine is not currently FDA-approved due to its Schedule 1 classification. SB 2308 will fund research through gifts, grants or donations and will require equal matching funds by the recipients, which will include Texas medical facilities 'equipped for cardiac-intensive monitoring' by a supervising physician, among other qualifications. 'By advancing ibogaine research, Texas has the opportunity to lead in neuroscience innovation, address urgent veteran health needs, and shape the future of mental health treatment nationwide,' the bill text reads. While legislation aimed at easing access to ibogaine moves forward, separate legislation to restrict access to another plant has also progressed. Texas lawmakers sent a bill banning non-medical THC products to Abbott for approval late last month. Still, Texas in recent years has become more open-minded to the use of psychedelic substances in treating mental health conditions. 'There's definitely been a shift in the openness and the receptivity of the field to this type of research,' said Greg Fonzo, Ph.D., co-director of the McGill Center for Psychedelic Research & Therapy at Dell Medical School. 'People who do undergo this treatment process, some of them respond well and have a benefit in terms of symptom reductions and feeling better,' Fonzo told KXAN earlier this year. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store